Entero Healthcare Solutions Limited (BOM:544122)
India · Delayed Price · Currency is INR 1,819.35
+23.05 (1.28%)
At close: Sep 11, 2026
BOM:544122 Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 79,012 | 54,293 | 49,468 | 42,948 | - | - | |
Market Cap Growth | 51.88% | 9.75% | 15.18% | - | - | - |
Enterprise Value | 83,462 | 57,396 | 48,939 | 54,183 | - | - |
Last Close Price | 1819.35 | 1245.85 | 1136.55 | 984.90 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 63.01 | 47.19 | 52.17 | 109.82 | - | - |
PS Ratio | 1.11 | 0.82 | 0.97 | 1.10 | - | - |
PB Ratio | 4.51 | 3.10 | 2.79 | 2.62 | - | - |
P/TBV Ratio | 8.51 | 5.85 | 3.82 | 2.98 | - | - |
P/FCF Ratio | 275.69 | 189.44 | - | - | - | - |
P/OCF Ratio | 82.13 | 56.44 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.17 | 0.87 | 0.96 | 1.38 | - | - |
EV/EBITDA Ratio | 26.98 | 24.28 | 32.56 | 57.03 | - | - |
EV/EBIT Ratio | 31.42 | 25.83 | 34.78 | 62.40 | - | - |
EV/FCF Ratio | 291.21 | 200.27 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.39 | 0.39 | 0.22 | 0.21 | 0.73 | 0.63 |
Debt / EBITDA Ratio | 2.19 | 2.56 | 2.25 | 3.03 | 6.91 | 14.83 |
Debt / FCF Ratio | - | 23.63 | - | - | - | - |
Net Debt / Equity Ratio | 0.22 | 0.22 | -0.04 | -0.34 | 0.55 | 0.44 |
Net Debt / EBITDA Ratio | 1.36 | 1.61 | -0.51 | -5.81 | 6.79 | 20.97 |
Net Debt / FCF Ratio | - | 13.30 | 0.87 | 13.14 | -6.51 | -5.52 |
Asset Turnover | - | 2.09 | 2.02 | 2.15 | 2.71 | 2.57 |
Inventory Turnover | - | 7.88 | 8.54 | 9.37 | 9.31 | 8.35 |
Quick Ratio | - | 1.00 | 1.60 | 2.56 | 1.02 | 1.04 |
Current Ratio | - | 1.58 | 2.46 | 3.34 | 1.64 | 1.84 |
Return on Equity (ROE) | - | 8.28% | 6.30% | 3.55% | -1.91% | -5.61% |
Return on Assets (ROA) | - | 4.41% | 3.48% | 2.97% | 2.04% | 0.30% |
Return on Invested Capital (ROIC) | 9.94% | 9.44% | 7.83% | 8.61% | 4.57% | 0.66% |
Return on Capital Employed (ROCE) | - | 11.00% | 7.60% | 5.00% | 5.80% | 0.70% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.59% | 2.12% | 1.92% | 0.91% | - | - |
FCF Yield | 0.36% | 0.53% | -1.78% | -0.98% | - | - |
Buyback Yield / Dilution | 0.08% | -0.00% | -20.45% | -779.74% | -163.71% | -1455.99% |